Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis-Reference-Cited by-同舟云学术

Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis

Published:2018-10 Issue:1 Volume:371 Page:50-62
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Yan Huaying,Guo Wenhao,Li Ke,Tang Mei,Zhao Xinyu,Lei Yi,Nie Chun-lai,Yuan Zhu

Funder

National Natural Science Foundation of China

Principal Fund of Chengdu Medical College

Publisher

Elsevier BV

Subject

Cell Biology

Reference40 articles.

1. Gene therapy for cancer treatment: past, present and future;Cross;Clin. Med. Res.,2006

2. Induction of apoptosis in cancer: new therapeutic opportunities;Ding;Ann. Med.,2002

3. Angiogenesis;Folkman;Annu. Rev. Med.,2006

4. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes;Filippov;Cancer Res.,2007

5. Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma;Lin;Oncotarget,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling;Journal of Experimental & Clinical Cancer Research;2024-02-08

2. Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study;Technology in Cancer Research & Treatment;2024-01

3. Current status of and progress in the treatment of malignant pleural effusion of lung cancer;Frontiers in Oncology;2023-01-20

4. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model;Frontiers in Bioscience-Landmark;2022-08-10

5. Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances;European Journal of Pharmacology;2022-01